Search research articles
Contact Us
Filters
Showing results (141-150 of 208) with videos related to
Page
of 21
Sort By:
Clinical Chemistry
|
December 1, 1988
Pyrochemiluminescence: real-time, cost-effective method for determining total urinary nitrogen in clinical nitrogen-balance studies
F N Konstantinides, K A Boehm, W J Radmer, et al.
Clinical Genitourinary Cancer
|
February 15, 2008
Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy
Guru Sonpavde, Ana Aparicio, Israel Guttierez, et al.
Investigational New Drugs
|
June 14, 2013
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trial
Craig Reynolds, Alexander I Spira, Larry Gluck, et al.
Clinical Therapeutics
|
August 6, 2013
Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects
Brian Zambrowicz, Ike Ogbaa, Kenny Frazier, et al.
Studies in Mycology
|
February 20, 2010
A molecular phylogenetic reappraisal of the Hysteriaceae, Mytilinidiaceae and Gloniaceae (Pleosporomycetidae, Dothideomycetes) with keys to world species
E W A Boehm, G K Mugambi, A N Miller, et al.
Biochemical and Biophysical Research Communications
|
December 15, 1988
The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets
P R Mayeux, H E Morton, J Gillard, et al.
Clinical Genitourinary Cancer
|
October 10, 2006
Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer
Michael Kolodziej, Marcus A Neubauer, Steven R Rousey, et al.
British Journal of Pharmacology
|
October 4, 2000
Caspase-1-inhibitor ac-YVAD-cmk reduces LPS-lethality in rats without affecting haematology or cytokine responses
G Mathiak, G Grass, T Herzmann, et al.
Biochemistry
|
October 11, 1994
Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA
M B De Young, J Kincade-Denker, C A Boehm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer
Michael G Teneriello, Paul C Tseng, Mark Crozier, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 208) with videos related to
Sort By:
Page
of 21
Clinical Chemistry
|
December 1, 1988
Pyrochemiluminescence: real-time, cost-effective method for determining total urinary nitrogen in clinical nitrogen-balance studies
F N Konstantinides, K A Boehm, W J Radmer, et al.
Clinical Genitourinary Cancer
|
February 15, 2008
Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy
Guru Sonpavde, Ana Aparicio, Israel Guttierez, et al.
Investigational New Drugs
|
June 14, 2013
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trial
Craig Reynolds, Alexander I Spira, Larry Gluck, et al.
Clinical Therapeutics
|
August 6, 2013
Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects
Brian Zambrowicz, Ike Ogbaa, Kenny Frazier, et al.
Studies in Mycology
|
February 20, 2010
A molecular phylogenetic reappraisal of the Hysteriaceae, Mytilinidiaceae and Gloniaceae (Pleosporomycetidae, Dothideomycetes) with keys to world species
E W A Boehm, G K Mugambi, A N Miller, et al.
Biochemical and Biophysical Research Communications
|
December 15, 1988
The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets
P R Mayeux, H E Morton, J Gillard, et al.
Clinical Genitourinary Cancer
|
October 10, 2006
Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer
Michael Kolodziej, Marcus A Neubauer, Steven R Rousey, et al.
British Journal of Pharmacology
|
October 4, 2000
Caspase-1-inhibitor ac-YVAD-cmk reduces LPS-lethality in rats without affecting haematology or cytokine responses
G Mathiak, G Grass, T Herzmann, et al.
Biochemistry
|
October 11, 1994
Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA
M B De Young, J Kincade-Denker, C A Boehm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer
Michael G Teneriello, Paul C Tseng, Mark Crozier, et al.
Page
of 21